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Absence of Brca2 causes genome instability by chromosome
breakage and loss associated with centrosome amplification
Andrew Tutt*, Anastasia Gabriel*, David Bertwistle*, Frances Connor*,
Hugh Paterson†, John Peacock‡, Gillian Ross‡ and Alan Ashworth*
Women heterozygous for mutations in the breast-cancer
susceptibility genes BRCA1 and BRCA2 have a highly
elevated risk of developing breast cancer [1]. BRCA1
and BRCA2 encode large proteins with no sequence
similarity to one another. Although involvement in DNA
repair and transcription has been suggested, it is still
not understood how loss of function of these genes
leads to breast cancer [2]. Embryonic fibroblasts (MEFs)
derived from mice homozygous for a hypomorphic
mutation (Brca2Tr2014) within the 3′ region of exon 11 in
Brca2 [3], or a similar mutation (Brca2Tr) [4], proliferate
poorly in culture and overexpress the tumour suppressor
p53 and the cyclin-dependent kinase inhibitor
p21Waf1/Cip1. These MEFs have intact p53-dependent
DNA damage G1–S [3,4] and G2–M checkpoints [4], but
are impaired in DNA double-strand break repair [3] and
develop chromosome aberrations [4]. Here, we report
that Brca2Tr2014/Tr2014 MEFs frequently develop
micronuclei. These abnormal DNA-containing bodies
were formed through both loss of acentric chromosome
fragments and by chromosome missegregation, which
resulted in aneuploidy. Absence of Brca2 also led to
centrosome amplification, which we found associated
with the formation of micronuclei. These data suggest a
potential mechanism whereby loss of BRCA2 may,
within subclones, drive the loss of cell-cycle regulation
genes, enabling proliferation and tumourigenesis.
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Results and discussion
As shown in Figure 1a, MEFs derived from day 13.5
Brca2Tr2014/Tr2014 embryos had a high frequency of spon-
taneous micronucleus formation (32% in passage 2),
increasing with passage number (52% in passage 3, χ2 for
trend = 53.2, p < 0.0001). In contrast, micronuclei were
rarely observed in MEFs derived from wild-type or het-
erozygous littermates, and did not increase in frequency
with passage number (3–4% in passage 2 and 3).
Micronuclei — which are a recognised consequence of
genome instability [5] — occur in cells that have completed
at least one mitosis and contain either an acentric chromo-
somal fragment formed by an unrepaired double-strand
break, or a lagged chromosome (that is, a chromosome that
fails to segregate into the daughter macronuclei at mitosis)
[6,7]. To differentiate between these two types of micronu-
clei, we used a pan-centromeric probe that hybridises to
the major (γ) satellite region of mouse centromeric DNA.
The centromere is the point of attachment of the kineto-
chore and mitotic spindle to the chromosome [8]. The
detection of the pan-centromeric probe within a micronu-
cleus indicates a lagged chromosome rather than an acen-
tric chromosome fragment [6,7] (Figure 1b,c). MEFs from
three Brca2Tr2014/Tr2014 embryos were scored for the pres-
ence or absence of centromeres in micronuclei; 71.4% of
micronucleus-containing cells had a lagged chromosome
(Figure 1d). If a micronucleus containing a lagged chromo-
some is inherited after cytokinesis by the incorrect daugh-
ter cell or is lost at cytokinesis, the daughter cells become
aneuploid. The remaining micronucleus-containing cells
(28.6%) had micronuclei formed by acentric fragments.
This occurs when a cell enters mitosis with an unrepaired
or mis-repaired chromosomal double-strand break. The loss
of these acentric fragments at cytokinesis will also result in
loss or gain of genetic material by daughter cells. 
As some Brca2Tr2014/Tr2014 MEFs contained more than one
micronucleus, we examined the relative frequency of loss
of whole chromosomes or acentric fragments. In MEFs
(passage 2) derived from two Brca2Tr2014/Tr2014 embryos,
we found a mean of 1.5 micronuclei for each micronu-
cleus-containing cell; 60.2% (95% confidence interval (CI)
56.4–64) of micronuclei were centromere-positive and
39.8% (95% confidence interval 36–43.6) were cen-
tromere-negative, indicating that the absence of wild-type
Brca2 leads to both the presence of chromosome breaks
and to chromosome missegregation at mitosis.
The centromeric major (γ) satellite represents 5–10% of
the mouse genome. A persistent DNA double-strand
break within this region may lead to the presence of the
major satellite signal within a micronucleus. If DNA
double-strand breaks or their misrepair are randomly
sited, the major satellite signal should be seen in only
5–10% of micronuclei [9]. The frequency of centromere-
positive micronuclei in Brca2Tr2014/Tr2014 MEFs is,
however, more consistent with failure of the mitotic
spindle/kinetochore mechanism to correctly segregate
chromosomes at mitosis; an alternative hypothesis might
be the preferential induction or misrepair of double-
strand DNA breaks within regions of centromeric satel-
lite repeats. 
The formation of micronuclei containing lagged chromo-
somes should lead to aneuploidy. By counting chromo-
some numbers in metaphase spreads, we found that 86%
(CI 79–92) of Brca2Tr2014/Tr2014 MEFs (passage 2) were
aneuploid compared with 20% (CI 15–27) for control
MEFs derived from Brca2+/+ littermates (Figure 1e,f).
This confirms that absence of Brca2 leads to aneuploidy.
The spindle pole mediates the correct segregation of chro-
mosomes into daughter nuclei through attachment of the
kinetochores of chromatids to spindle microtubules [10].
The centrosome, which nucleates the spindle pole and
determines the axes of mitosis, normally duplicates once
per cell cycle, at the G1–S boundary [11]. The two daughter
centrosomes migrate to opposite poles before segregating a
diploid chromosome set to that pole. To determine whether
the chromosome missegregation in Brca2Tr2014/Tr2014 MEFs
might be associated with abnormalities of centrosome
number, we counted the number of centrosomes per cell in
MEFs (passage 2 and 3) derived from Brca2Tr2014/Tr2014
embryos and from their wild-type and heterozygous litter-
mates. MEFs were derived from three sets of littermates,
and centrosomes visualised by immunofluorescent labelling
of γ tubulin, which is highly specific to the centromere, in
conjunction with β-tubulin labelling of microtubules. The
absence of the wild-type Brca2 gene product was associated
with abnormalities in centrosome number (Figure 2); the
centrosome number increased with time in culture and
passage number (Figure 3a). The median centrosome
number of Brca2Tr2014/Tr2014 cells at late second passage and
at third passage was 3 and 4, respectively, with interquartile
ranges (IQRs) of 2–5 and 2–6, respectively. MEFs derived
from wild-type and heterozygous littermates had a median
centrosome number of 2 (IQR 1–2) at both second and third
passage The differences in frequency of centrosomes per
cell between Brca2Tr2014/Tr2014 and Brca2+/+ or Brca2+/Tr2014
MEFs were statistically significant at all time points
(Kruskal–Wallis test, p < 0.0001).
The proportion of Brca2Tr2014/Tr2014 MEFs that showed
centrosome amplification rose from 44% in passage 2 to
65% in passage 3 (χ2 for trend = 49.4, p < 0.0001). In con-
trast, only 10% of Brca2+/+ MEFs exhibited centrosome
amplification at both passage 2 and 3 (Figure 3b). Centro-
some amplification was associated with micronucleus for-
mation in Brca2Tr2014/Tr2014 MEFs (relative risk 3.3,
Fisher’s exact test, p < 0.0001; Table 1). Despite this asso-
ciation, centrosome amplification was present in the
absence of a micronucleus and vice versa; following an
abnormal mitosis and cell division, only one daughter
might inherit an abnormal centrosome number or a
micronucleus. An amplified centrosome number might
also result in an aberrant but bipolar mitosis (Figure 2d)
with missegregation of chromosomes into the two daugh-
ter macronuclei but without the formation of a micronu-
cleus. In an interphase population of cells, we cannot
exclude the possibility that some of the γ-tubulin bodies
are non-functional centrosome fragments.
Human tumours arise through a multi-step process
involving mutations in a number of oncogenes and
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Figure 1
Spontaneous micronucleus formation, chromosome missegregation and
the presence of chromosome breaks at mitosis in Brca2Tr2014/Tr2014
MEFs. (a) Percentage of Brca2+/+, Brca2+/Tr2014 and Brca2Tr2014/Tr2014
MEFs at passage 2 and 3 that contain micronuclei. Error bars
represent CIs of the proportion. (b) Brca2Tr2014/Tr2014 MEF containing
a single centromere-positive micronucleus. (c) Binucleate
Brca2Tr2014/Tr2014 MEF with a centromere-negative micronucleus. In
(b,c), the cells were hybridised with a Cy3-labelled pan-centromeric
DNA probe (red); DNA was stained with 4,6-diamidino-2-phenylindole
(DAPI, blue). (d) Proportion of micronuclei-containing MEFs with a
lagged chromosome. Error bars represent CIs of the proportion.
(e,f) Frequency histogram of metaphase chromosome number counted
on 140 metaphase spreads from (e) Brca2+/+ and (f) Brca2Tr2014/Tr2014
MEFs, both at passage 2.
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tumour suppressor genes [12]; underlying genomic insta-
bility may accelerate this process [13]. Genomic instabil-
ity at the chromosomal level is a common feature of
human tumours, occurs early in tumourigenesis and com-
monly leads to the development of aneuploidy [12].
Tumours exhibiting chromosome instability do not show
genomic instability at the nucleotide sequence level and
vice versa [14]. Chromosome segregation at mitosis is
tightly regulated; abnormalities of the centrosome,
mitotic spindle and kinetochore apparatus can lead to
chromosome missegregration and consequent aneuploidy
[8,10,12,15–17]. Breast tumours in heterozygotes for
BRCA1 and BRCA2 mutations have lost their wild-type
allele [2] and are most frequently aneuploid [18,19].
Here, we report that loss of wild-type Brca2 leads to chro-
mosome missegregation and aneuploidy in association
with amplification of centrosome number. This suggests
that loss of BRCA2 may result in aneuploidy as a conse-
quence of abnormality in spindle-pole number. Whether
Brca2 directly regulates centrosome duplication or
spindle-pole function remains to be established. 
The high frequency of micronuclei in Brca2Tr2014/Tr2014
MEFs, indicating the completion of aberrant mitoses,
may reflect the absence of a checkpoint monitoring the
number of spindle poles [20]. Nevertheless, we cannot
exclude the possibility that Brca2Tr2014/Tr2014 MEFs have
an intrinsic defect in the mitotic spindle checkpoint. The
additional presence of unrepaired chromosome breaks
and intact p53-mediated G1–S and G2–M checkpoints
may explain the proliferative failure in Brca2Tr2014/Tr2014
MEFs [3,4]. We hypothesise that sporadic loss of wild-
type BRCA2 within the breast epithelial cells of BRCA2
heterozygotes will, in sub-clones, drive the loss of cell-
cycle checkpoint-regulation genes, enabling proliferation.
Indeed, lack of p53 rescues proliferative failure in
Brca2Tr2014/Tr2014 MEFs (F.C. and D.B., unpublished
observations). The mitotic spindle checkpoint is also reg-
ulated by p53 [21], and absence of p53 leads to centro-
some amplification and chromosome missegregation [22].
The combined loss of function of p53 and BRCA2 would
be expected to cause accelerated genomic instability and
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Figure 2
Centrosome amplification in Brca2Tr2014/Tr2014 MEFs. Cells were
stained with fluorescein isothiocyanate (FITC)-conjugated anti-γ-tubulin
antibody (green), Cy3-conjugated anti-β-tubulin antibody (red) and the
DNA dye 7-amino actinomycin D (blue). Centrosomes appear
green/yellow because of colocalisation of γ tubulin and β tubulin at the
centrosome. Microtubules appear red and DNA blue. (a) Brca2+/+
interphase MEFs at 60 × magnification showing 1–2 centrosomes per
cell. The bar represents 50 µm. (b) Brca2Tr2014/Tr2014 interphase MEFs
at the same magnification showing centrosome amplification and the
presence of a micronucleus. (c,d) Brca2Tr2014/Tr2014 mitotic MEFs. The
one in (c) has three functional centrosomes and a tripolar spindle; the
one in (d) has four functional centrosomes and a bipolar mitosis.
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Figure 3
The frequency of centrosome amplification increases with passage
number in Brca2Tr2014/Tr2014 MEFs. (a) Frequency distribution
histograms of centrosome number per cell in Brca2+/+ and
Brca2Tr2014/Tr2014 MEFs at passage 2 and 3. Centrosome number was
grossly increased, and increased further with passage number, in
Brca2Tr2014/Tr2014 MEFs. The histograms for Brca2+/Tr2014 MEFs is not
shown but is essentially identical to that for Brca2+/+ MEFs. (b) The
proportion of Brca2Tr2014/Tr2014 MEFs that demonstrate centrosome
amplification was significantly higher than in Brca2+/Tr2014 or Brca2+/+
MEFs and increased with passage number. Error bars represent CIs of
the proportion.
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tumourigenesis. While this manuscript was in prepara-
tion, it was reported that a homozygous Brca1 mutation
also leads to centrosome amplification and chromosome
missegregation [23]. As BRCA2 is known to complex with
BRCA1 in mitotic cells [24], BRCA1 and BRCA2 may
function within a common pathway that maintains accu-
rate chromosome segregation at mitosis, and thus loss of
function of either gene causes chromosome instability
and leads to tumourigenesis.
In summary, the absence of wild-type Brca2 led to the
development of spontaneous micronuclei, a marker of
chromosome instability, and the proportion of cells con-
taining micronuclei increased with passage number. We
have shown that chromosome missegregation is the major
mechanism leading to formation of these micronuclei and
have confirmed that aneuploidy is the consequence.
Absence of Brca2 also led to increased centrosome
number in these cells. Centrosomes nucleate mitotic spin-
dles and form the poles of division at mitosis. The
observed abnormality of centrosome number suggests a
mechanism for the disordered chromosome segregation
observed in Brca2Tr2014/Tr2014 MEFs and thus a potential
mechanism by which absence of wild-type BRCA2 may
lead to tumourigenesis as a result of loss of chromosome
stability in epithelial cells.
Supplementary material
Additional methodological details are available at http://current-
biology.com/supmat/supmatin.htm.
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Table 1
Centrosome amplification is associated with micronucleus
formation in Brca2 Tr2014/Tr2014 MEFs.
Number of Number of cells Number of cells Total
centrosomes with micronuclei without number
per cell micronuclei of cells
> 2 181 92 273
1–2 29 116 145
Total number of cells 210 208 418
Absence of Brca2 causes genome instability by chromosome
breakage and loss associated with centrosome amplification
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S1
Supplementary materials and methods
Cell culture
Generation of MEFs from Brca2+/Tr2014 intercrosses was performed as
described [S1]. Passage 1 MEFs from genotyped littermate quarter-
embryo aliquots, stored in 0.5 ml 10% DMSO in DMEM supplemented
with 10% FCS, 2 mM L-glutamine and penicillin under liquid nitrogen,
were thawed into medium as above and plated into T-175 culture flasks
overnight. For the assessment of micronucleus frequency and for
immunofluorescence experiments, 2 × 105 cells were re-plated into
6 cm tissue culture dishes containing 18 mm glass coverslips and were
cultured at 37°C in a 10% CO2 atmosphere; 72 h after thawing and
start of culture, cells were washed, trypsinised, split 1:2 and replated in
6 cm dishes with coverslips for passage 3 time points. For fluorescence
in situ hybridisation (FISH) experiments, 4 × 104 MEFs were plated in
4 ml medium in slide chamber flasks (Nunc) and cultured as above.
Immunofluorescence microscopy and micronucleus assay
Subconfluent MEFs of genotype Brca2+/+, Brca2+/Tr2014 and
Brca2Tr2014/Tr2014 derived from three separate litters were washed in
PBS and fixed in 100% methanol at –20°C for 10 min and then rehy-
drated in PBS. Coverslips were blocked in PBS with 10% FCS for
30 min, then incubated with anti-γ-tubulin monoclonal antibody (Sigma
GTU-88) at 1:200 dilution in PBS with 4% FCS for 1 h, washed three
times with PBS, incubated with donkey anti-mouse IgG antibody
(Jackson Immuno Research Laboratories Inc, 1:200 dilution) in PBS for
1 h, washed three times in PBS and incubated with Cy3-conjugated
anti-β-tubulin monoclonal antibody (Sigma) for 1 h. DNA was stained
with either 7-amino-actinomycin D (2 µg/ml), then washed and mounted
on Mowiol (Calbiochem), or mounted in Mowiol with DAPI (1.5 µg/ml).
Determination of micronucleus frequency
Cells were viewed using a Zeiss Axioskop fluorescence microscope
with standard epifluorescent filters for DAPI, Cy3/Texas Red, and FITC,
and a 63 or 100 × Plan Neofluor objective. At least 200 MEFs were
sampled from each of three embryos per genotype for each culture
time point in three independent experiments. The presence or absence
of a micronucleus in each cell was recorded.
Determination of centrosome number per cell
Cells were viewed using a Nikon Eclipse 600 fluorescence microscope
with standard epifluorescence filters for Cy3/Texas Red and FITC. The
number of FITC-labelled γ-tubulin foci were counted through the entire
thickness of each cell. At least 200 MEFs were sampled from each of
three embryos per genotype for each culture time point in at least three
independent experiments. The number of centrosomes in each cell was
recorded. The microscope was linked to an MRC 1024 confocal imaging
system equipped with a krypton argon laser and Laser Sharp software.
Images for figures were made using a full thickness image reconstructed
by superimposition of 1 µm interval sections through the cell.
FISH with pan-centromeric (γ) major satellite probe
Subconfluent MEFs of Brca2Tr2014/Tr2014 genotype from two separate
litters in two independent experiments were grown in slide flasks as
described above and cultured for the indicated time, washed in PBS
before fixation in fresh 3:1 methanol:glacial acetic acid at 4°C for 30 min
and air dried overnight. Slides were dehydrated through an ethanol
series and were denatured and hybridised with a Cy3-conjugated mouse
major satellite pan-centromeric probe according to the manufacturer’s
protocol (Cambio Ltd). After hybridisation, slides were mounted with
Vectashield containing 1.5 µg/ml DAPI, coverslipped and viewed using a
Zeiss Axioskop with standard epifluorescence filters for DAPI and Texas
Red/Cy3 and 63 × and 100 × Plan Neofluor objective linked to a Photo-
metrics Series 200 CCD camera and IPLab Spectrum software. At least
200 micronucleus-containing MEFs derived from each of three
Brca2Tr2014/Tr2014 embryos were scored for the presence of either a Cy3
signal-positive or a signal-negative micronucleus or both. The total
number of all individual signal-positive or signal-negative micronuclei
from at least 200 micronucleus-containing MEFs derived from each of
two Brca2Tr2014/Tr2014 embryos was also recorded.
Metaphase chromosome counts
Passage 2 MEFs from Brca2Tr2014/Tr2014 and Brca2+/+ littermates were
colcemid-blocked for 6 h (Gibco BRL, final concentration 0.1 µg/ml),
harvested and resuspended in 0.8% trisodium citrate at 37°C for
30 min and then fixed in three changes of ice cold 3:1 methanol:acetic
acid and dropped on acid-cleaned cold slides. Slides were dried
overnight and stained with 3% Giemsa in Gurr buffer pH 6.8 and
mounted in DPX. Metaphase spreads were photographed, and chro-
mosome number was counted on at least 140 metaphase spreads per
genotype from two litter sets by a blinded observer.
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